METTL3 and colorectal carcinoma: In CRC, METTL3 directly induces the m6A–glucose transporter type 1 (GLUT1)–mechanistic target of the rapamycin complex 1 (mTORC1) axis, promoting glucose uptake, lactate production, and CRC progression.